Your browser doesn't support javascript.
loading
Prognostic role of gait speed in worsening heart failure.
Cirelli, Camilla; Limonta, Raul; Carioli, Greta; D'Elia, Emilia; Ameri, Pietro; Inciardi, Riccardo Maria; Ghirardi, Arianna; Fazzini, Luca; Perra, Ferdinando; Rizzola, Ginevra; Chiesa, Erika; Tomasoni, Laura; Montisci, Roberta; Gavazzi, Antonello; Senni, Michele; Gori, Mauro.
Affiliation
  • Cirelli C; Department of Medicine and Surgery, University of Milano Bicocca, Piazza dell'Ateneo Nuovo 1, 20126, Milan, Italy.
  • Limonta R; Department of Medicine and Surgery, University of Milano Bicocca, Piazza dell'Ateneo Nuovo 1, 20126, Milan, Italy.
  • Carioli G; FROM Research Foundation, Papa Giovanni XXIII Hospital, Piazza OMS 1, 24127, Bergamo, Italy.
  • D'Elia E; Department of Medicine and Surgery, University of Milano Bicocca, Piazza dell'Ateneo Nuovo 1, 20126, Milan, Italy; Cardiovascular Department, Papa Giovanni XXIII Hospital, Piazza OMS 1, 24127, Bergamo, Italy.
  • Ameri P; Department of Internal Medicine, University of Genova, Viale Benedetto XV 6, 16132, Genova, Italy.
  • Inciardi RM; Institute of Cardiology, ASST Spedali Civili di Brescia, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Piazzale Spedali Civili 1, 25123, Brescia, Italy.
  • Ghirardi A; FROM Research Foundation, Papa Giovanni XXIII Hospital, Piazza OMS 1, 24127, Bergamo, Italy.
  • Fazzini L; Clinical Cardiology Unit, Department of Medical Sciences and Public Health, University of Cagliari, Cittadella Universitaria di Monserrato, Strada Provinciale 8, 09042, Monserrato, Cagliari, Italy.
  • Perra F; Clinical Cardiology Unit, Department of Medical Sciences and Public Health, University of Cagliari, Cittadella Universitaria di Monserrato, Strada Provinciale 8, 09042, Monserrato, Cagliari, Italy.
  • Rizzola G; Department of Internal Medicine, University of Genova, Viale Benedetto XV 6, 16132, Genova, Italy; Cardiology Unit, Medical Sciences Department, ASST Bergamo Est, Via Paderno 21, 24068, Seriate, Italy.
  • Chiesa E; FROM Research Foundation, Papa Giovanni XXIII Hospital, Piazza OMS 1, 24127, Bergamo, Italy.
  • Tomasoni L; In charge of Surgical, Cardiovascular & Neuroscience Nursing Department, Department of Health and Social Professions, ASST Papa Giovanni XXIII, Piazza OMS, 1, 24127, Bergamo, Italy.
  • Montisci R; Clinical Cardiology Unit, Department of Medical Sciences and Public Health, University of Cagliari, Cittadella Universitaria di Monserrato, Strada Provinciale 8, 09042, Monserrato, Cagliari, Italy.
  • Gavazzi A; FROM Research Foundation, Papa Giovanni XXIII Hospital, Piazza OMS 1, 24127, Bergamo, Italy.
  • Senni M; Department of Medicine and Surgery, University of Milano Bicocca, Piazza dell'Ateneo Nuovo 1, 20126, Milan, Italy; Cardiovascular Department, Papa Giovanni XXIII Hospital, Piazza OMS 1, 24127, Bergamo, Italy.
  • Gori M; Department of Medicine and Surgery, University of Milano Bicocca, Piazza dell'Ateneo Nuovo 1, 20126, Milan, Italy; Cardiovascular Department, Papa Giovanni XXIII Hospital, Piazza OMS 1, 24127, Bergamo, Italy. Electronic address: mgori@asst-pg23.it.
Eur J Intern Med ; 2024 Aug 07.
Article de En | MEDLINE | ID: mdl-39117554
ABSTRACT

BACKGROUND:

Worsening Heart Failure (WHF) is associated with adverse prognosis. Identifying novel prognostic markers in WHF is crucial. Gait speed (GS), a validated frailty index, is an easily obtainable parameter that may aid in reclassifying the risk of HF patients. We assessed the independent prognostic role of GS in WHF patients.

METHODS:

We studied 171 patients with chronic HF with worsening congestion symptoms and inadequate response to standard therapies, requiring intravenous diuretic treatment. The primary outcome was a composite of all-cause mortality or HF hospitalization. We assessed the association and the incremental value of GS, as compared to other clinical confounders, with the primary outcome.

RESULTS:

The mean age was 76±11 years, 66 % were male, median BNP was 481 pg/ml, and median ejection fraction was 40 %. Over a median follow-up of 11.3 months, 71 events occurred. Lower GS was significantly associated with a higher risk of events (HR of 4.03, 95 % CI 2.25-7.21), along with neutrophil to lymphocyte ratio, BNP, QRS duration, natremia, and previous myocardial infarction. When added to the MAGGIC risk score and the other significant confounders identified, GS significantly enhanced the model risk prediction (Harrell's C-index 0.75 vs 0.71, p < 0.001). At Classification And Regression Tree analysis, GS≤0.8 m/s was the first parameter to be considered to risk stratify the population.

CONCLUSIONS:

GS, an easily obtainable marker of frailty, may contribute to improve the risk stratification of patients with WHF.
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Eur J Intern Med Sujet du journal: MEDICINA INTERNA Année: 2024 Type de document: Article Pays d'affiliation: Italie

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Eur J Intern Med Sujet du journal: MEDICINA INTERNA Année: 2024 Type de document: Article Pays d'affiliation: Italie